BNP Paribas Financial Markets
ALBO

BNP Paribas Financial Markets’s Albireo Pharma Inc ALBO Stock Holding History

BNP Paribas Financial Markets’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,334
Closed -$72K – 4130
2022
Q4 		$72K Sell
3,334
-10,506
-76% -$222K ﹤0.01% 3336
2022
Q3 		$268K Buy
13,840
+7,338
+113% +$152K ﹤0.01% 3355
2022
Q2 		$129K Buy
6,502
+2,997
+86% +$79.1K ﹤0.01% 3268
2022
Q1 		$105K Sell
3,505
-2,096
-37% -$61.4K ﹤0.01% 3350
2021
Q4 		$130K Sell
5,601
-1,327
-19% -$35.3K ﹤0.01% 3518
2021
Q3 		$216K Buy
6,928
+1,843
+36% +$57K ﹤0.01% 3012
2021
Q2 		$179K Sell
5,085
-4,307
-46% -$140K ﹤0.01% 2895
2021
Q1 		$331K Buy
9,392
+7,148
+319% +$264K ﹤0.01% 2798
2020
Q4 		$84.2K Sell
2,244
-1,196
-35% -$43.5K ﹤0.01% 3295
2020
Q3 		$115K Buy
3,440
+2,220
+182% +$64.7K ﹤0.01% 3041
2020
Q2 		$32.3K Sell
1,220
-3,293
-73% -$77.7K ﹤0.01% 3210
2020
Q1 		$73.9K Buy
4,513
+3,004
+199% +$66.1K ﹤0.01% 3357
2019
Q4 		$38.4K Sell
1,509
-24
-2% -$480 ﹤0.01% 3789
2019
Q3 		$30.7K Buy
1,533
+508
+50% +$13.2K ﹤0.01% 3745
2019
Q2 		$33K Sell
1,025
-872
-46% -$29.2K ﹤0.01% 3668
2019
Q1 		$61.1K Buy
1,897
+1,697
+849% +$45.7K ﹤0.01% 3396
2018
Q4 		$4.91K Sell
200
-98
-33% -$2.59K ﹤0.01% 3594
2018
Q3 		$9.82K Sell
298
-2
-0.7% -$65 ﹤0.01% 3740
2018
Q2 		$10.7K Buy
+300
New +$9.72K ﹤0.01% 3748

Other funds holding ALBO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

BNP Paribas Financial Markets's ALBO Position: Q1 2023 in Review

BNP Paribas Financial Markets sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 3,334 shares — an estimated $72K sold.

BNP Paribas Financial Markets first reported a position in ALBO in Q2 2018 and held it in 19 quarters. The position peaked at $331K in Q1 2021. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

  • BNP Paribas Financial Markets reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 3,334 Albireo Pharma Inc shares in Q1 2023, an estimated $72K.
  • BNP Paribas Financial Markets first reported a position in Albireo Pharma Inc in Q2 2018 and held it in 19 quarters.
  • BNP Paribas Financial Markets's Albireo Pharma Inc position peaked at $331K in Q1 2021.
  • 3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2023, filed 12 May 2023.